Financial results
Financial results
Un-Audited Financial Results_31.12.2022
Unaudited Financial Results for the quarter ended 30th September, 2022
Unaudited Financial Results for the quarter ended 30th June, 2022
Audited Financial Results for the year ended 31st March 2022
Unaudited Financial Results for the quarter ended 31st December 2021
Unaudited Financial Results for the half year ended 30th September 2021
Unaudited Financial Results for the quarter ended 30th June 2021
Audited Financial Results for the year ended 31st March 2021
Unaudited Financial Results for the quarter ended 31st December 2020
Unaudited Financial Results for the half year ended 30th September 2020
Unaudited Financial Results for the quarter ended 30th June 2020
Audited Financial Results for the year ended 31st March 2020
Unaudited Financial Results for the quarter ended 31st December 2019
Unaudited Financial Results for the half year ended 30th September 2019
Unaudited Financial Results for the quarter ended 30th June 2019
Audited Financial Results for the year ended 31st March 2019
Unaudited Financial Results for the quarter ended 31st December 2018
Unaudited Financial Results for the half year ended 30th September 2018
Unaudited Financial Results for the quarter ended 30th June 2018
Audited Financial Results for the year ended 31st March 2018
Unaudited Financial Results for the quarter ended 31st December 2017
Unaudited Financial Results for the half year ended 30th September 2017
Unaudited Financial Results for the quarter ended 30th June 2017
Audited Financial Results for the year ended 31st March 2017
Unaudited Financial Results for the quarter ended 31st December 2016
Unaudited Financial Results for the half year ended 30th September 2016
Unaudited Financial Results for the quarter ended 30th June 2016
Audited Financial Results for the year ended 31st March 2016
Unaudited Financial Results for the quarter ended 31st December 2015
Unaudited Financial Results for the half year ended 30th September 2015
Unaudited Financial Results for the quarter ended 30th June 2015
Details of Nodal Officer – IEPF
Shri Govardhan M. Dhoot – Chairman & Managing Director
Company Name: Mangalam Drugs & Organics Ltd.
CIN: L24230MH1972PLC116413
Registered Office:
Rupam Building, 3rd Floor, 239, P D’ Mello Road (Near GPO),
Mumbai – 400 001, Maharashtra, INDIA.
Tel: +91 – 22 – 2261 6200 / 6300
Email ID: cs@mangalamdrugs.com
Unclaimed Dividend 2017-18 Interim Dividend
Secretarial Department
Mr. Jayant Barde – Company Secretary & Compliance Officer
Mangalam Drugs & Organics Ltd.
Rupam Building, 3rd Floor,
239, P D’ Mello Road (Near GPO),
Mumbai – 400 001. Maharashtra, INDIA.
Tel: +91 – 22 – 2261 6200 / 6300
Email ID: cs@mangalamdrugs.com
R & T Agent
Link Intime India Pvt. Ltd.
C-101, 247 Park, L.B.S Marg,
Vikhroli (West), Mumbai-400083.
Tel No.: 91-22-49182670
Fax: 91 22 49186060
Email ID: cs@mangalamdrugs.com
Grievance redressal and other relevant details:
Mr. Jayant Barde – Company Secretary & Compliance Officer
Mangalam Drugs & Organics Ltd.
Rupam Building, 3rd Floor,
239, P D’ Mello Road (Near GPO),
Mumbai – 400 001. Maharashtra, INDIA.
Tel: +91–22–2261 6200/6300
Email ID: cs@mangalamdrugs.com
